...viral vectors, including retroviruses and AAVs 2016 Sartorius AG (Xetra:SRT) Evaluate and test synthetic promoters with Sartorius’...

...undisclosed grant from the U.K. government’s Innovate UK. The partners declined to provide further details. Sartorius AG...

...Suppurativa Clinical Response (HiSCR) at week 12; change in hidradenitis suppurativa count, skin pain and Sartorius...

...Suppurativa Clinical Response (HiSCR) at week 12; change in hidradenitis suppurativa count, skin pain and Sartorius...

...approved Sartorius' offer to acquire TAP Biosystems for €33 million ($44.6 million ) in cash. Sartorius...
...phases of product and process development. The deal is expected to close by year end. Sartorius AG...

...skin pain as measured by the patient's global assessment of skin pain and change in Sartorius...

...Heinio, along with the employees and management team of the liquid handling business, transferred to Sartorius...
...succeeds Heinio as president and CEO (see BioCentury, Oct. 31). Biohit Oyj (HSE:BIOBV), Helsinki, Finland Sartorius AG...

...and eight sales subsidiaries, is expected to close in December. Biohit Oyj (HSE:BIOBV), Helsinki, Finland Sartorius AG...

...Raised: €2 million ($2.9 million) Shares: 677,966 Price: €2.95 Shares after offering: 13.6 million Investor: Sartorius...

...disclosed. Crucell N.V. (Euronext:CRXL; CRXL), Leiden, the Netherlands DSM Biologics N.V. , Heerlen, the Netherlands Sartorius AG...